Teen anxiety: what the evidence says actually helps
Anxiety disorders in young people are treatable. In the largest trial, combining CBT with an SSRI worked best, and both beat placebo. Talking therapy alone also clearly outperforms no treatment.
Does 4-7-8 breathing calm you down? The exact pattern is barely tested
Slow breathing does shift the body toward calm, but the popular 4-7-8 count has almost no direct trial evidence, and the breathwork that has been tested in a large study is a different pattern.
Does listening to music reduce stress? Modestly, but reliably
Two meta-analyses of 104 trials found music lowered both felt stress and physical markers like heart rate. The effect is consistent and moderate — larger for how stressed people feel than for blood pressure.
The people delivering mental health care to the world's poorest carry more than we count
Task-sharing therapy to lay community workers is the backbone of WHO's plan for closing the treatment gap. A synthesis of 28 studies asks what the model costs the workers themselves.
Lay-helper therapy cut distress in Polish migrant workers, Dutch trial finds
In the RESPOND randomised trial, guided self-help and remote problem-solving delivered by non-professionals cut anxiety and depression scores well below usual care at follow-up.
Do school phone bans improve teen mental health? The first direct test found no difference
Restrictive English schools cut phone use during the school day but not overall — and teenagers' wellbeing was no better than at schools that allow phones. What tracks with worse mental health is heavy, problematic use.
Does ashwagandha work for stress? The trials say maybe, the safety data say be careful
Randomised trials show lower self-reported stress and anxiety, but the certainty is low, the studies are small and wildly inconsistent, and a separate evidence strand flags liver and thyroid risks.
After a cyclone hits India's coast, psychiatric medicine sales jump for a year
A five-year panel study found sales of mental-disorder medicines rose 144% in a cyclone's landfall year and 173% the next in coastal districts, with no measurable effect further inland.
Two Gaza studies begin to measure the war's mental-health toll
Among 383 dialysis patients, 83.6% screened for moderate-to-extreme anxiety and 58% for PTSD; a separate study of 250 displaced adolescents found trauma exposure tracking closely with post-traumatic symptoms.
Collaborative care beats usual care for depression — but the edge fades over years
A Cochrane review of 79 trials and 24,308 patients found the primary-care model helps with depression and anxiety, modestly in the short and medium term and not at all in the very long term.
Mental health apps aimed at teenagers are mostly commercial, and barely tested for harm
A survey of seven countries found the youth mental health app market dominated by paid journaling and meditation apps. The AI-powered ones show early promise on symptoms — and none had checked for harm.
Meditation apps do a little, even without a teacher — and mostly for stress
Across 34 trials, mindfulness apps produced small effects on stress, anxiety and depression, and none on general distress. A 2026 review confirms they can help without a facilitator — at low certainty.
Young Australians' mental health is recovering. Teenagers are recovering slowest.
Under-25s lost about 5 points on a 100-point wellbeing scale between 2019 and 2021. Adults 19 to 24 have clawed back two-thirds of that loss. Teenagers 15 to 18 have recovered barely a third.
Gaza war amputees scored far higher on disability than matched controls
A cross-sectional study of 96 war amputees, 53 caregivers and 95 community controls found sharply elevated disability and psychiatric symptoms, and argued for combined physical and mental-health rehabilitation.
Half the mental health apps proven in trials cannot be downloaded
A review of 110 studies found that 52% of trialled self-guided apps were publicly available — and that evidence quality had no bearing on which ones made it to an app store.
Semaglutide users had 51% lower suicidal ideation risk than older GLP-1 users
Tirzepatide and semaglutide showed comparable psychiatric risk profiles against each other over two years. Against earlier GLP-1 drugs, semaglutide came out ahead on all three measures.
Sleep got worse during Ramadan and mood mostly didn't — in a cohort of 30 Saudi women
Stress peaked during the fasting month and fell afterwards, but depression and anxiety stayed flat. The consistent finding across every phase was that sleep quality tracked mental health.
Across 18 countries, loneliness predicted decline and death. Being alone did not.
A registered report fit identical models to 11 longitudinal studies covering 175,070 people. The subjective feeling carried the signal; the objective count of social contacts largely did not.
The mental health gap in endometriosis opens years before the diagnosis does
A Danish registry study of 136,842 women found elevated antidepressant and anxiolytic prescribing in the decade preceding diagnosis, with psychiatric hospital contacts rising about five years before.
At-home ketamine's entire evidence base came from the companies selling it
A systematic review screened 3,857 records and found three eligible studies, every one produced by a US commercial provider and every one at critical risk of bias.
In veterans, psilocybin's anxiety relief tracked entirely with depression improvement
Anxiety, quality of life and PTSD symptoms all improved after a single dose in this 15-person trial. Once researchers accounted for depression improvement, those effects mostly disappeared.
AI therapy chatbots reduce symptoms in trials. The safety scaffolding is thin
Pooled across 48 trials, chatbots cut depression, anxiety and stress by small amounts. But a review of purpose-built mental health chatbots found crisis-referral protocols underdeveloped and missed suicidal ideation.
NICE reviewed 30 digital mental health tools. The same evidence gaps kept recurring
A cross-sectional analysis of NICE evaluations found 78 supporting studies behind 30 technologies — and consistent holes in comparators, cost of delivery and adverse-event reporting.
Do mental health apps work? The evidence is real, small, and fragile
The largest syntheses find apps beat doing nothing on depression and anxiety by about a third of a standard deviation — but the edge shrinks against real treatment, and one umbrella review found no convincing proof.
Machine learning looked for the teenagers school mindfulness helps. It barely found them.
A secondary analysis of 8,376 adolescents built two models to predict who benefits from school-based mindfulness training. Both found a subgroup — and the difference in outcomes was trivial.
Only 5% of Lebanese children who screened positive had ever received care
The barriers parents named most often were cost and the absence of any nearby service — not stigma, which the field has spent years treating as the main obstacle.
The mental health app features people use most are not the ones that work
A meta-regression of 169 trials coded 34 therapeutic ingredients. The most common — psychoeducation, relaxation, mindfulness — were not the ones that best predicted getting better.
A 2967-adolescent cohort looked for bushfire harm at 24 months and did not find it
Australian teenagers harmed by the Black Summer fires showed no elevated depression, anxiety, distress, insomnia or suicidality two years later. The result runs against a systematic review published months earlier.
Eight phone calls cut loneliness in older adults — and the effect held a year later
A 1,151-person Hong Kong trial used trained lay counsellors, not clinicians, and no internet. The effect sizes are small, and the authors are explicit that they do not know whether it travels.
GBD 2023: the world got healthier per person while total health loss grew
Age-standardised disability-adjusted life-years fell 12.6% since 2010, but the raw total rose 6.1% to 2.80 billion. Anxiety, depression and diabetes rose fastest even after adjusting for ageing.
A ten-society guideline on tapering benzodiazepines, and data on who is starting them
The guidance is built on one negative instruction: do not stop abruptly in patients likely to be physically dependent. Hong Kong records show the sharpest prescribing rise in 18-to-25-year-olds.
Two reviews on populations the health evidence base barely covers
Seventeen longitudinal studies of young carers, all from high-income countries. And 247 studies of women in prison, nearly all at high risk of bias in at least one domain.